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Abstract
Background: To present and compare population-based and antenatal-care (ANC) sentinel surveillance HIV prevalence
estimates among women in a rural South African population where both provision of ANC services and family planning
is prevalent and fertility is declining. With a need, in such settings, to understand how to appropriately adjust ANC
sentinel surveillance estimates to represent HIV prevalence in general populations, and with evidence of possible biases
inherent to both surveillance systems, we explore differences between the two systems. There is particular emphasis on
unrepresentative selection of ANC clinics and unrepresentative testing in the population.
Methods: HIV sero-prevalence amongst blood samples collected from women consenting to test during the 2005 annual
longitudinal population-based serological survey was compared to anonymous unlinked HIV sero-prevalence amongst
women attending antenatal care (ANC) first visits in six clinics (January to May 2005). Both surveillance systems were
conducted as part of the Africa Centre Demographic Information System.
Results: Population-based HIV prevalence estimates for all women (25.2%) and pregnant women (23.7%) were
significantly lower than that for ANC attendees (37.7%). A large proportion of women attending urban or peri-urban
clinics would be predicted to be resident within rural areas. Although overall estimates remained significantly different,
presenting and standardising estimates by age and location (clinic for ANC-based estimates and individual-residence for
population-based estimates) made some group-specific estimates from the two surveillance systems more predictive of
one another.
Conclusion: It is likely that where ANC coverage and contraceptive use is widespread and fertility is low, population-
based surveillance under-estimates HIV prevalence due to unrepresentative testing by age, residence and also probably
by HIV status, and that ANC sentinel surveillance over-estimates prevalence due to selection bias in terms of age of
sexual debut and contraceptive use. The results presented highlight the importance of accounting for unrepresentative
testing, particularly by individual residence and age, through system design and statistical analyses.
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In sub-Saharan Africa, surveillance of women attending
antenatal care (ANC) is often used to measure prevalence
and monitor trends in HIV infection. However, when
applying ANC-based HIV prevalence estimates to the gen-
eral population the following biases should be consid-
ered: only pregnant women are eligible for testing
(structural bias) [1]; women who become pregnant and
attend ANC facilities are sexually active and not using con-
traceptives (self selection bias) [1,2]; attendance varies by
factors associated with HIV [2]; and, HIV-infected women
may be less likely to become pregnant [1-7].
Fertility among HIV-infected women in sub-Saharan
Africa is lower than in HIV-uninfected women, except in
women aged 15–19 years [7]. In young women the selec-
tive pressure of sexual debut on pregnancy and HIV infec-
tion resulted in higher fertility rates among the HIV
infected [7]. Six studies conducted in high fertility popu-
lations in sub-Saharan Africa showed that HIV prevalence
in pregnant women was lower than in women of repro-
ductive age overall [6]. In populations of southern Africa
with low fertility and extensive contraceptive use, bias due
to the selection for pregnancy in ANC-based HIV preva-
lence estimates could be smaller [8]. This is because
women who use modern methods of family planning
may take more effective measures to avoid HIV infection
[1], and sub-fertility in HIV-infected women will have a
weaker effect [8].
Bias due to the purposive selection of ANC facilities
should also be considered when applying ANC-based
prevalence estimates to a population [1,8]. Over-represen-
tation of ANC clinics in urban areas, where HIV preva-
lence is usually relatively high, may result in HIV
prevalence levels being exaggerated [8]. However, evi-
dence of urban and peri-urban based clinics attracting
large numbers of women from rural areas, where HIV
prevalence tends to be lower, would mitigate this [8].
Population-based surveys are more representative of the
general population than ANC-based surveys as they
include non-pregnant and non-ANC attending pregnant
women, as well as men. However, limitations exist and of
particular concern is the effect of non-response on HIV
prevalence estimates.
Population-based surveys have been conducted in several
sub-Saharan African countries [8-20], including South
Africa where primary health care services are free, use of
modern contraception is high and the total fertility rate is
low [21]. It has been suggested that women using modern
methods of family planning may take more effective
measures to avoid HIV infection [1]. In KwaZulu Natal,
South Africa, information collected by the Africa Centre
Demographic Information System (ACDIS) [21-23], in
2001 shows 51.7% of women aged 15 to 49 years to have
ever used a modern contraceptive method, the median
age of first sexual intercourse to be 17.7 years, and fertility
between 1980/84 and 2000/01 to have declined in
women aged 18 years and older [21].
In this paper we present and compare HIV prevalence esti-
mates from both population-based surveillance and ANC
sentinel surveillance within an area of sub-Saharan Africa
with high contraceptive use and low fertility. We identify
and explore differences, and reasons for differences,
between the two surveillance systems, with particular
emphasis on unrepresentative selection of clinics in ANC
sentinel surveillance and unrepresentative testing in pop-
ulation-based surveillance. Where estimates from the two
surveillance systems differ we explore methods to reduce
these differences.
Methods
The ACDIS is conducted in the rural sub-district of Hla-
bisa in northern KwaZulu-Natal, South Africa. It covers
435 square kilometres and a total resident population of
85123 (unpublished data as of January 2005). The 11284
homesteads within the area have been enumerated and
mapped using a geographic information system (GIS).
The area includes a formally designated urban township,
peri-urban areas (settlements with a population density of
more than 400 people per km2), and rural areas. The rural
population live in scattered homesteads that are not con-
centrated in villages.
Population-based linked anonymous HIV testing was
introduced within the ACDIS in July 2003. Sampling for
testing is based upon information collected routinely
through demographic surveillance [21-23]. All resident
women aged 15 to 49 years and men aged 15 to 54 years,
were eligible for annual HIV testing through a finger-prick
blood sample on filter paper and approached for inclu-
sion in the survey [24-27]. Additionally, 10% of non-resi-
dent members of households located within the study
area, in above age groups, were randomly selected for test-
ing. To facilitate a comparison with ANC-based estimates,
only resident women were included in these analyses. A
resident is an individual, reported by the household
informant, who keeps their daily belongings, and who
spends most nights, within the survey area [23,24].
Results are those from the second annual HIV survey (Jan-
uary to December, 2005).
Ethical approval was received from the University of Kwa-
Zulu Natal (E029/2003). All individuals eligible for HIV
testing were asked for written informed consent and
informed about the potential risks to becoming aware of
ones HIV status, about how and where HIV test resultsPage 2 of 12
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Estimated travel time to clinic and resulting catchments of the six government clinics within the surveillance area offering ANC by residency typeFigure 1
Estimated travel time to clinic and resulting catchments of the six government clinics within the surveillance area offering ANC 
by residency type.
BMC Public Health 2007, 7:160 http://www.biomedcentral.com/1471-2458/7/160and post-test counselling may be accessed and, if found
positive, how they may be referred to a local clinic for fur-
ther screening and assessment of eligibility for antiretrovi-
ral treatment. The choice to provide a test sample and to
access the HIV test result rests fully with the individual.
In December 2001, Hlabisa Health sub-district became
the first rural district in South Africa to provide antiretro-
viral drugs for the prevention of HIV mother to child
transmission. Between January and May 2005, alongside
the Prevention of Mother-to-Child Transmission
(PMTCT) programme, venous blood was taken for rou-
tine ANC laboratory tests from all women attending first
ANC visits at all six government clinics delivering ANC
within the ACDIS. Surplus blood from these samples was
also used for anonymous unlinked HIV testing. Parity and
age was linked to a woman's HIV test result. Results can-
not be linked back to the individual as, apart from date of
birth, no personal identifiers were collected.
For each participant the most likely clinic at which ante-
natal care was obtained was predicted on the basis of a
GIS accessibility model that estimated travel time to the
six government clinics within the surveillance area offer-
ing ANC. The model took into account the quality and
distribution of the road network, barriers to movement
and the likelihood of utilising public transport to access
care [28]. The six clinics were categorised as mixed peri-
Table 1: Women eligible for population-based HIV testing and women reported through ANC sentinel surveillance by residency 
location and clinic catchment
Clinic catchment type
Residency location Peri-urban/Urban Rural/peri-urban Rural Total
n % n % n % n %
Women eligible for population-based 
testing ever reporting a pregnancy 
(reported residency, reported clinic attend-
ance)
Urban 9 5.1 0 0.0 1 0.5 10 2.2
Peri-urban 97 55.1 18 22.5 15 7.9 130 29.1
Rural 70 39.8 62 77.5 174 91.6 306 68.6
Total 176 100 80 100 190 100 446 100
All women eligible for population-based 
HIV testing (reported residency, predicted 
clinic attendance)
Urban 943 19.5 0 0.0 0 0.0 943 6.5
Peri-urban 2748 56.9 1302 41.2 367 5.9 4417 30.5
Rural1 1139 23.6 1859 58.8 5873 94.1 9116 63.0
Total 4830 100 3161 100 6240 100 14476 100
Pregnant women eligible for population-
based testing2,3 (reported residency, 
predicted clinic attendance)
Urban 52 11.1 0 0.0 0 0.0 52 3.6
Peri-urban 279 59.7 136 40.6 43 6.9 458 31.7
Rural 136 29.1 199 59.4 582 93.1 934 64.7
Total 467 100 335 100 625 100 1444 100
ANC sentinel surveillance (predicted resi-
dency, reported clinic attendance)
Urban 116 19.5 0 0.0 0 0.0 116 10.5
Peri-urban 339 56.9 72 41.2 23 6.6 434 39.0
Rural 140 23.6 104 58.8 317 93.4 561 50.5
Total4 595 100 176 100 340 100 1111 100
1 Total includes 245 women not assigned to one of the six clinics within the ACDIS
2 Total includes 17 women not assigned to one of the six clinics within the ACDIS
3 Women reported to the ACDIS as pregnant between 01/07/04 and 30/06/05
4 Total excludes 35 women for whom there was no HIV test result (total ANC sample 1146)Page 4 of 12
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on the basis of their predicted constituent catchment pop-
ulations.
As ANC sentinel surveillance does not collect residency
information, ANC attendees were proportionally assigned
to one of the three residency types (urban/peri-urban/
rural) based on the underlying predicted catchment pop-
ulation of the clinic attended. To assess the reliability of
the clinic accessibility model in predicting ante-natal
attendance we compared the prediction of the model with
reported ante-natal clinic usage amongst women ever
reporting a pregnancy within the ACDIS.
Pearson chi2 values and all confidence intervals presented
are at the 95% level. STATA 9.0 (Stata Corp., College Sta-
tion, Texas, USA) was used for univariate and multivariate
analyses. To account for unrepresentative testing, popula-
tion-based and ANC-based HIV prevalence estimates were
standardised for age, age and location (clinic for ANC-
based estimates and individual-residence for population-
based estimates), and age and clinic catchment by apply-
ing the respective prevalence estimates to samples of
women adjusted to proportionally match ACDIS popula-
tion level data on all women aged 15 to 49 as of 1st Janu-
ary 2005. Women reported to the ACDIS during twice
yearly fieldworker visits as having been pregnant (regard-
less of outcome) during the period 1st July 2004 and 30th
June 2005, who were also eligible for population-based
testing, were identified to assist comparative analyses.
Unrepresentative testing by HIV status was analysed by
linking records (based on a unique identifier allocated to
all participants) between the first (July 2003 to December
2004) and second (January to December, 2005) popula-
tion-based HIV surveys. The proportion of women with a
negative HIV test result in the first survey who also con-
sented to test in 2005 was applied to all women with a
first survey test result from whom consent was sought in
2005.
Table 2: Population-based HIV survey 2005: rates of testing consent and HIV prevalence estimates
Women Age group Women 
eligible for 
inclusion 
in the 
population
-based 
survey
Of women 
eligible for HIV 
testing those 
asked to 
consent to test
Of all women 
contacted those 
consenting to 
test
Of all women 
contacted those 
not consenting 
to test
Diagnosed with 
HIV infection3
95% CIs Odds 
ratios
95% CIs
n %1 n %2 n %2 n %
All 15–195 3669 3207 87.4 1658 51.7 1549 48.3 114 6.9 5.7 8.3 - - -
20–24 2967 2307 77.8 1030 44.6 1277 55.4 294 28.7 26.0 31.6 5.4 4.3 6.8
25–29 1842 1478 80.2 501 33.9 977 66.1 248 49.6 45.1 54.1 13.2 10.2 17.2
30–34 1563 1327 84.9 470 35.4 857 64.6 220 47.0 42.4 51.6 11.9 9.2 15.5
35+ 4435 4032 90.9 1634 40.5 2398 59.5 451 27.7 25.6 30.0 5.2 4.1 6.4
Total 14476 12351 85.3 5293 42.9 7058 57.1 1327 25.2 24.0 26.4 - - -
Pregnant4 15–195 335 311 92.8 172 55.3 139 44.7 19 11.2 6.9 16.9 - - -
20–24 475 427 89.9 200 46.8 227 53.2 52 26.1 20.2 32.8 2.8 1.6 5.0
25–29 244 215 88.1 77 35.8 138 64.2 32 41.6 30.4 53.4 5.7 2.9 10.9
30–34 183 169 92.3 64 37.9 105 62.1 21 32.8 21.6 45.7 3.9 1.9 7.9
35+ 207 197 95.2 95 48.2 102 51.8 20 21.3 13.5 30.9 2.1 1.1 4.3
Total 1444 1319 91.3 608 46.1 711 53.9 144 23.8 20.5 27.4 - - -
Parity 
(all 
women)
Nulliparous5 5282 4324 81.9 1960 45.3 2364 54.7 232 11.9 10.5 13.4 - - -
Parity 1+ 9194 8027 87.3 3333 41.5 4694 58.5 1095 33.0 31.5 34.7 3.7 3.1 4.3
Residency 
location 
(all 
women)
Rural5 9116 7790 85.5 3560 45.7 4230 54.3 755 21.3 20.0 22.7 - - -
Peri-urban 4417 3756 85.0 1636 43.6 2120 56.4 547 33.5 31.2 35.9 1.9 1.6 2.1
Urban 943 805 85.4 97 12.0 708 88.0 25 26.0 17.6 36.0 1.3 0.8 2.1
1 Presented as a proportion of all women eligible for inclusion in the 2005 population-based survey
2 Presented as a proportion of all women contacted by HIV survey fieldworkers between January and December 2005
3 HIV test result not available for 27 women (8 nulliparous; 19 parity 1+;4 pregnant women) providing a blood sample
4 Reported as pregnant between 1st July 2004 and 30th June 2005
5 Baseline groups for odds ratiosPage 5 of 12
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Residency location and clinic catchment
Clinic attendance by residency type (where one or both is
either predicted or reported) is presented for women eligi-
ble for testing in the population-based survey (Figure 1
and Table 1) as well as for women attending ANC first vis-
its (Table 1). There was a 77% (2513/3281) agreement
between reported antenatal clinic usage among women
ever reporting a pregnancy (for whom information on
both ANC clinic of attendance and residency is recorded)
and usage as predicted by the clinic accessibility model.
Compared to general clinic usage as reported across
23,000 homesteads within Hlabisa health sub-district
[27], model predictions were 91% accurate.
Population based HIV surveillance
Ten percent (1444/14476) of eligible women reported
being pregnant between 1st July 2004 and 30th June 2005.
Of the 14476 women eligible for HIV testing in 2005,
85.3% (12351) were contacted and asked to provide a
blood sample. This proportion varied by age-group, parity
and pregnancy status (all p < 0.001). Of those eligible,
36.6% (5293/14476) of women agreed to test, and of
those contacted 42.9% (5293/12351) tested (Table 2).
The proportion of women contacted who agreed to test
varied by age-group, parity, residency location and clinic
catchment (all p < 0.001). Pregnant women aged 15–19
years were most likely to consent to test (55.3%), whereas
urban residents were least likely (12%). By age-group, the
proportion of women consenting to test compared to
those refusing significantly differed in all groups (p <
0.001) apart from the 20 to 24 year group (p = 0.111).
A definitive HIV test result was available for 99.5% (5266/
5293) of women testing. Amongst all women, HIV preva-
lence was 25.2% (95% CIs: 24.0%, 26.4%, median age 24
years), and in pregnant women 23.8% (95% CIs: 20.5%,
27.6%, n = 604, median age 21 years). Prevalence of HIV
varied significantly by age-group amongst all women and
pregnant women (both p < 0.001), (Table 2). Crude and
age-standardised estimates for pregnant women were sig-
nificantly lower than for women with a previous live birth
Table 3: ANC sentinel surveillance 2005: HIV prevalence estimates
Sample1 (n) Diagnosed with HIV infection 95% CIs Odds ratio 95% CIs
n %
HIV Prevalence2 1111 419 37.7 34.9 40.6 - - -
Antenatal Clinic by location 
type2
Urban3 595 243 40.8 36.9 44.9 - - -
Peri-urban 375 135 36.0 31.1 41.1 0.8 0.6 1.1
Rural 141 41 29.1 30.0 38.4 0.6 0.4 0.9
Antenatal Clinic by 
Catchment type2
Peri-urban/urban3 595 243 40.8 36.9 44.9 - - -
Rural/peri-urban 176 68 38.6 31.4 46.3 0.9 0.7 1.3
Rural 340 108 31.8 26.8 37.0 0.7 0.5 0.9
Parity2 03 430 106 24.7 20.6 29.0 - - -
1 324 150 46.3 40.8 51.9 2.6 1.9 3.6
2 157 85 54.1 46.0 62.1 3.6 2.5 5.3
3+ 166 67 40.4 32.8 48.2 2.1 1.4 3.0
Not known 34 11 32.4 17.4 50.5 - - -
Age 15–193 251 49 19.5 14.8 25.0 - - -
20–24 408 151 37.0 32.3 41.9 2.4 1.7 3.5
25–29 210 114 54.3 47.3 61.2 4.9 3.2 7.4
30–34 120 62 51.7 42.4 60.9 4.4 2.7 7.1
35+ 104 38 36.5 27.3 46.6 2.4 1.4 3.9
Not known 18 5 27.8 9.7 53.5 - - -
1 35 women for whom there was no HIV test result removed from these analyses
2 Estimates includes 18 women for whom age was not reported
3 Baseline groups for odds ratiosPage 6 of 12
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than for non-pregnant nulliparous women (both p <
0.001).
Antenatal sentinel surveillance
An HIV test result was available for 96.9% (1111/1146) of
women attending ANC first visits (median parity 1) and
both a test result and date of birth available for 95.4%
(1093/1146) of women (median age 23 years). Among
the 1111 women for whom there was a test result, 12.7%
(141) were reported as attending one of four rural-based
clinics, 33.8% (375) one of two peri-urban-based clinics
and 53.6% (595) the urban-based clinic (Table 1). Overall
prevalence was 37.7% (414/1111), and was highest in the
urban-based clinic with a predicted peri-urban/urban
catchment, in women with a previous live birth, and
amongst those aged 25 to 29 years (Table 3). Prevalence
of HIV infection was shown to vary significantly by resi-
dency location (p = 0.032); clinic catchment (p = 0.028);
parity and age (both p < 0.001). Standardising for age
removed the significant difference in HIV prevalence esti-
mates by residency location and clinic catchment (p =
0.084 and p = 0.057, respectively).
Comparing HIV prevalence estimates from the two 
surveillance systems
Age-specific patterns of HIV prevalence in the ANC and
population-based surveillance systems were similar (Fig-
ure 2). However, most crude population-based estimates
were statistically lower (p < 0.05) than crude ANC-based
estimates when disaggregated by pregnancy status, parity,
location, and clinic catchment type (Table 4). Only
among the 25–29 and 30–34 age-groups and the peri-
urban location (residency or clinic) group did the two sys-
tems provide statistically similar estimates.
The following adjustment factors would be necessary to
adjust crude ANC-based estimates to match those pro-
vided by the population-based survey: 0.7 amongst all
women; 0.6 amongst pregnant women; 0.5 amongst nul-
liparous women; 0.7 amongst women with a previous live
birth. By primarily adjusting for an over-sampling of
women aged 15–19 years in the population-based surveil-
lance, and for an under-sampling of women aged 35+
years in ANC surveillance, age-standardisation reduced
differences between the two sources of prevalence esti-
mates, and removed the statistically significant difference
in the rural location group (Table 4). Although age-stand-
ardisation increased the overall population-based esti-
mate by 9.1% and decreased the ANC-based estimate by
4.2%, the difference between the two overall adjusted esti-
mates remained significant. Age and clinic/residence loca-
tion standardisation removed a statistically significant
difference between the surveillance methods in women
with a previous live birth (Table 4).
A test result from the first population-based survey was
available for 28.8% (2030/7058) of women who refused
to test in 2005. Women with a negative HIV test result
from the first population-based survey were more likely to
test in 2005 than those with a positive result (61.1%
(2322/3801) compared to 52.6% (611/1162), p < 0.001).
The figures for pregnant women were statistically similar
to those for all women. Applying the consent rate of
61.1% to all women with a first survey test result from
whom consent was sought in 2005 made little difference,
with the adjusted estimate of 26.4% (1426/5392) remain-
ing significantly lower than the overall ANC-based esti-
mate, (both p < 0.001). Prevalence of HIV among women
who tested during the first survey but who refused during
the second survey was 1.3 times higher than prevalence
among women who tested in both (27.1% [551/2030]
compared to 20.8% [611/2933]).
Discussion
The results of this paper show population-based estimates
of HIV prevalence in women to be consistently lower than
ANC-based estimates. Although there are several possible
explanations for this difference (discussed below), one
possible explanation that should first be considered is
unrepresentative testing in the population-based survey
Within the population-based survey, women in the 25–29
and 30–34 age-groups presented both the highest HIV
prevalence estimates and the lowest proportions agreeing
to test. Women resident in the urban area were the overall
group least likely to consent to test. Prevalence estimates
among groups where the proportion of women contacted
consenting to test is particularly low should be interpreted
with caution. The proportions of women consenting to
test are presented as of those contacted and not as of the
Population-based and ANC sentinel-surveillance age-specific HIV prevalence estimatesFig re 2
Population-based and ANC sentinel-surveillance age-specific 
HIV prevalence estimates.Page 7 of 12
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terms of HIV status those contacted differ to those not
contacted. Further analyses are necessary to explore this
possible bias.
It is likely that within the ACDIS area, where provision of
ANC clinics offering PMTCT services is comprehensive
[29], many women will already be aware of their HIV sta-
tus, and this may well influence their decision to agree to
give a sample in population-based surveillance. Although
testing consent in 2005 was lower amongst women with a
previous HIV positive test result than amongst women
with a previous negative test result, crudely adjusting for
testing bias by HIV status had little effect. It should be
noted that although test results are made available to par-
ticipants [27] a low rate of uptake of test results [25]
ensures a surveillance test result is no indication of an
individual being aware of their HIV status.
A review of 20 national population-based surveys across
sub-Saharan Africa suggests non-responders are likely to
have a higher prevalence of HIV than responders and, by
applying the most extreme scenario to account for such
bias, an adjustment factor of 1.34 may be required [30].
Our analyses suggest prevalence among women testing in
the first population-based survey but not the second was
Table 4: Comparing population-based and ANC sentinel-surveillance HIV prevalence estimates
ANC based HIV 
prevalence 
estimates1
Population based 
HIV prevalence 
estimates
Ratio of ANC and 
population based 
estimates2
C hi2 (p)3
All women Crude 37.9 25.2 1.50 < 0.001
15–19 19.5 6.9 2.83 < 0.001
20–24 37.0 28.7 1.29 0.002
25–29 54.3 49.6 1.09 0.254
30–34 51.7 47.0 1.10 0.362
35+ 3 6.5 27.7 1.32 0.053
Age standardised 36.2 27.5 1.32 < 0.001
Age & location4 31.7 27.5 1.15 0.005
Age & catchment5 35.6 27.7 1.29 < 0.001
Nulliparous Crude 24.8 11.9 2.08 < 0.001
Age standardised 21.3 15.5 1.37 0.003
Age & location4 20.1 15.9 1.26 0.037
Age & catchment5 20.6 16.0 1.29 0.022
Parity 1+ Crude 46.4 33.0 1.41 < 0.001
Age standardised 43.0 34.4 1.25 < 0.001
Age & location4 37.0 34.1 1.09 0.153
Age & catchment5 41.6 34.5 1.21 < 0.001
Pregnant women Crude - 23.8 1.59 < 0.001
Age standardised - 25.2 1.44 < 0.001
Age & location4 - 25.3 1.25 0.006
Age & catchment5 - 25.0 1.42 < 0.001
Clinic location (ANC); residency 
location (population)
Urban Crude 40.7 26.0 1.56 0.006
Age standardised 39.2 27.1 1.47 0.023
Peri-urban Crude 36.5 33.5 1.09 0.277
Age standardised 36.8 36.5 1.01 0.930
Rural Crude 29.2 21.3 1.37 0.028
Age standardised 28.5 23.2 1.22 0.151
Projected clinic catchment 
(ANC); residence within 
projected clinic catchment 
(population)
Peri-urban/urban Crude 40.7 30.5 1.33 < 0.001
Age standardised 38.2 33.5 1.14 0.039
Rural/peri-Urban Crude 39.4 27.2 1.45 0.001
Age standardised 38.2 29.3 1.30 0.018
Rural Crude 32.0 20.8 1.54 < 0.001
Age standardised 32.3 22.7 1.42 < 0.001
1 18 women excluded from the analyses with age not known
2 Ratio based on ANC totals when no direct comparable ANC group
3 Difference between two proportions (ANC-based HIV prevalence estimate compared to the population-based estimate)
4 Standardisation based on age and residency location (urban, rural and peri-urban) distribution within the ACDIS population
5 Standardisation based on age and predicted ANC clinic catchment (peri-urban/urban, peri-urban/rural and rural) distribution within the ACDIS populationPage 8 of 12
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However, it is unlikely that this figure is representative of
all women refusing to test and therefore, it was not used
to adjust the population-based estimate.
Although statistically similar, the overall population-
based estimate for women of 25.2% (95% CIs: 24.0%,
26.4%) was lower than the estimate of 27.3% (95% CIs:
26.3%, 28.4%) from the first ACDIS population-based
survey [24,31] and the estimate of 30.4% (95% CIs:
24.7%, 36.7%) amongst 15–49 year old women resident
in 2005 in a province wide population-based survey of
KwaZulu Natal [32].
The overall ANC-based estimate of 37.7% (95% CIs:
34.9%, 40.6%), although statistically similar, falls mid-
way between estimates of 35.3% (95% CIs: 33.7, 36.9%)
amongst pregnant women tested within the Hlabisa sub-
District PMTCT programme January to June 2005 [29,33]
and 39.1% (95% CIs: 36.8%, 41.4%) amongst 15–49 year
old ANC clinic attendees in a province wide survey of
KwaZulu Natal 2005 [34]. The estimate presented in this
paper of 40.7% (95% CIs: 36.7%, 44.8%) amongst
women attending the urban clinic is comparable to the
estimate of 41.2% (95% CIs: 34.7%, 47.9%) for the same
clinic in December 1998 [35].
Comparative analyses of population-based and ANC-
based estimates elsewhere
Modern contraceptive use in South Africa is the highest in
Sub-Saharan Africa and fertility the lowest [21]. In con-
trast with the results presented here, regional and national
studies in sub-Saharan Africa, including Tanzania [36-38],
Uganda [39], Zambia [18-20] and Cameroon [2], found
ANC-based estimates to be lower than estimates amongst
women in the population. Across a range of sub-Saharan
African countries ANC-based estimates have been shown
to be on average 28% lower than population-based esti-
mates for women [1]. Comparing estimates at the
national level with other national or regional estimates
can be problematic due to bias as a result of site selection.
ANC-based results presented here and those from other
regional surveys conducted elsewhere in sub-Saharan
Africa show higher prevalence estimates among women
attending urban-based clinics than clinics based else-
where [8].
A study based on regional estimates in three sub-Saharan
African countries suggested that to convert ANC-based
estimates amongst primagravida to all childless women in
general populations with high contraceptive use (20%+)
an adjustment factor of 0.6 would be necessary [1].
Amongst multigravida it was suggested an adjustment fac-
tor of 1.1 would be necessary to represent all mothers [1].
In the ACDIS population, an adjustment factor of 0.5 was
necessary to match the ANC-based estimate amongst nul-
liparous women to that provided by the population-based
survey, whereas amongst women with a previous live
birth the figure was 0.7.
Additional explanations for differences in prevalence 
estimates
a) Age, contraceptive-use and fertility
The largest differences between the two surveillance sys-
tems were in women aged 15–19 years and nulliparous
women. That ANC-based estimates were so much higher
than population-based estimates in these two groups
probably reflects self-selection bias amongst ANC attend-
ees with regards age of sexual debut and non-contracep-
tive use. Although women aged 25–34 years have the
lowest consent rates for population-based testing and
highest HIV prevalence, adjusting for unrepresentative
testing by age only removes a significant difference within
the rural location group.
In areas with high contraceptive use ANC-based estimates
would be expected to exceed population-based estimates
among women whereas, where fertility rates are reduced
due to prevalence of HIV infection the opposite is true [1].
Although use of modern contraceptives is high and fertil-
ity has declined within the ACDIS [21], and although HIV
prevalence amongst currently pregnant women in the
population was estimated to be significantly lower than
that amongst women with a previous live birth, it was not
possible to separate out the influences of contraceptive
use or HIV related sub-fertility.
b) Unrepresentative selection of clinics in ANC sentinel surveillance
A study of bias in ANC-based surveillance data suggested
that an over-estimation of HIV prevalence due to an over
representation of urban-based clinics could be mitigated
if urban and peri-urban based clinics were shown to be
attracting large numbers of women from rural areas [8].
The results presented here show the urban-based clinic to
contribute over half of all ANC-based HIV test results and
suggest over 70% of women attending the urban or peri-
urban clinics are resident in an area type other than that
where the clinic is located. It should be noted, that the rel-
atively small size of the urban and peri-urban areas
[28,40] may facilitate this process. Furthermore, the
urban-based clinic is located at the southeast extremity of
the study area and may well attract individuals from
urban areas lying outside of the study area. It was for this
reason ANC-based estimates were standardised by age.
Since ANC surveillance did not collect residency location
it was not possible to assess whether ANC clinic attend-
ance outside of residency location was associated with
HIV status.Page 9 of 12
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tive model for clinic catchments presented both previ-
ously [28,40] and here, and despite predicted high levels
of clinic attendance outside of residency location, stand-
ardising estimates by age and clinic catchment did little to
reduce differences between the two sources of prevalence
estimates. However, standardising estimates by age and
location did reduce differences. Age and location stand-
ardisation may well provide the most robust estimates for
rural and peri-urban areas (standardised estimates for
urban location [area with highest ANC-based prevalence
estimate, highest out-of-area clinic attendance and lowest
population-based consent rate] remained significantly
different).
c) Unrepresentative reporting and under-reporting of pregnancies
In an area with high ANC coverage [29] and where preg-
nant women in the population present the highest overall
rate of testing consent and similar rates of testing consent
by HIV status than amongst all women, it is difficult to
explain why crude and standardised population-based
estimates presented for pregnant women and by parity
differ so greatly to ANC-based estimates. It is possible that
pregnant women in the two populations are not fully
comparable.
A study in Hlabisa sub-district showed that 91% of home-
steads normally utilise the most accessible primary health
clinic [28]. However, it is likely that a proportion of
women attending the urban clinic reside outside of the
surveillance area. Under-reporting of pregnancies ending
in early term HIV-related pregnancy loss in ACDIS would
result in pregnant women living with HIV/AIDS, who may
have already attended an ANC first visit, not being identi-
fied within the population-based survey. Not only are fur-
ther analyses of how pregnancies are reported to
demographic systems warranted, so are analyses of how
multiple methods of HIV testing in an area influence deci-
sions to test within population-based surveillance. A
greater understanding of how high levels of contraceptive
use and possible HIV associated sub-fertility effect HIV
prevalence estimates is also required.
Conclusion
The findings of this study suggest that where ANC cover-
age is high, population-based HIV surveillance systems
under-estimate HIV prevalence due to unrepresentative
testing by HIV status that results in unrepresentative test-
ing by age and residence. The results also suggest that
despite evidence of large numbers of women from rural
areas (where HIV prevalence tends to be lower) attending
urban and peri-urban clinics, in an area with high contra-
ceptive use and low fertility, resulting in selection bias due
to age of sexual debut, ANC sentinel surveillance over-
estimates prevalence. Understanding how to appropri-
ately adjust ANC sentinel surveillance estimates to repre-
sent HIV prevalence in general populations is important
since ANC clinics continue to be a relatively cheap and
timely source of data.
The findings of this study highlight the possible biases
inherent to both surveillance systems and suggest that
attention should be paid to unrepresentative HIV testing,
particularly by age and residency location. Analysing pop-
ulation-based HIV prevalence estimates, and comparing
them to ANC-based estimates, also highlights the impor-
tance of not assuming population-based estimates equate
to a gold standard.
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